NCT06541067 2026-01-26
POSALLO
Nantes University Hospital
Phase 2 Recruiting
Clinical Trials
9 trialsNCT03828773 2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA Recruiting
NCT07185503 2025-09-22
Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety
Institute of Hematology & Blood Diseases Hospital, China
Recruiting
NCT03796533 2022-02-24
Posa-Pk
Hospices Civils de Lyon
Phase NA Unknown
NCT02358499 2020-12-22
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Children's Mercy Hospital Kansas City
Phase 1 Completed
NCT02875743 2020-04-02
King's Invasive Aspergillosis Study II
King's College Hospital NHS Trust
Phase 4 Completed
NCT00936117 2019-02-27
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01200355 2018-05-07
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center
Phase 4 Completed
NCT00750737 2016-09-29
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
M.D. Anderson Cancer Center
Phase 3 Completed